EUVIMEDEUVIMED entdecken
Crossref

The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing

Abdul Waheed Khan iD, Misbah Aziz, Karly C Sourris, Man K S Lee, Aozhi Dai, Anna M D Watson, Scott Maxwell, Arpeeta Sharma, Ying Zhou, Mark E Cooper iD, Anna C Calkin, Andrew J Murphy und 2 weitere

Diabetes · 01.09.2024 · 73 (9) · 1495-1512

DOI: 10.2337/db23-0167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, online erschienen am 21.06.2024. Verfasst von Abdul Waheed Khan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia. Hauptthemen laut MEDLINE: Atherosclerosis, Transcription Factor AP-1, Single-Cell Analysis, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Australian Research Council, National Heart Foundation of Australia, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advances in treatment, atherosclerotic cardiovascular disease remains the leading cause of death in patients with diabetes. Even when risk factors are mitigated, the disease progresses, and thus, newer targets need to be identified that directly inhibit the underlying pathobiology of atherosclerosis in diabetes. A single-cell sequencing approach was used to distinguish the proatherogenic transcriptional profile in aortic cells in diabetes using a streptozotocin-induced diabetic Apoe−/− mouse model. Human carotid endarterectomy specimens from individuals with and without diabetes were also evaluated via immunohistochemical analysis. Further mechanistic studies were performed in human aortic endothelial cells (HAECs) and human THP-1–derived macrophages. We then performed a preclinical study using an activator protein-1 (AP-1) inhibitor in a diabetic Apoe−/− mouse model. Single-cell RNA sequencing analysis identified the AP-1 complex as a novel target in diabetes-associated atherosclerosis. AP-1 levels were elevated in carotid endarterectomy specimens from individuals with diabetes compared with those without diabetes. AP-1 was validated as a mechanosensitive transcription factor via immunofluorescence staining for regional heterogeneity of endothelial cells of the aortic region exposed to turbulent blood flow and by performing microfluidics experiments in HAECs. AP-1 inhibition with T-5224 blunted endothelial cell activation as assessed by a monocyte adhesion assay and expression of genes relevant to endothelial function. Furthermore, AP-1 inhibition attenuated foam cell formation. Critically, treatment with T-5224 attenuated atherosclerosis development in diabetic Apoe−/− mice. This study has identified the AP-1 complex as a novel target, the inhibition of which treats the underlying pathobiology of atherosclerosis in diabetes. Article Highlights

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisTranscription Factor AP-1Single-Cell AnalysisDiabetes Mellitus, ExperimentalAnimalsHumansMiceMaleEndothelial CellsSequence Analysis, RNA

Substanzen

Transcription Factor AP-1

Autor:innen und Institutionen

  • Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia.
  • Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia.
  • School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, Victoria, Australia.
  • School of Health & Biomedical Sciences, Royal Melbourne Institute of Technology University, Bundoora, Australia.
  • Leibniz Institute for Diabetes Research, Heinrich Heine University, Dusseldorf, Germany.

ORCID-Profile: Abdul Waheed Khan, Mark E Cooper, Karin A M Jandeleit-Dahm

Förderung

  • Australian Research Council
  • National Heart Foundation of Australia
  • National Health and Medical Research Council

Zitieren

APA

Khan, A. W., Aziz, M., Sourris, K. C., Lee, M. K. S., Dai, A., Watson, A. M. D., Maxwell, S., Sharma, A., Zhou, Y., Cooper, M. E., Calkin, A. C., Murphy, A. J., Baratchi, S., & Jandeleit-Dahm, K. A. M. (2024). The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing. Diabetes, 73(9), 1495-1512. https://doi.org/10.2337/db23-0167

Vancouver

Khan AW, Aziz M, Sourris KC, Lee MKS, Dai A, Watson AMD, et al. The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing. Diabetes. 2024;73(9):1495-1512. doi:10.2337/db23-0167

BibTeX
@article{Khan2024,
  author = {Khan, Abdul Waheed and Aziz, Misbah and Sourris, Karly C and Lee, Man K S and Dai, Aozhi and Watson, Anna M D and Maxwell, Scott and Sharma, Arpeeta and Zhou, Ying and Cooper, Mark E and Calkin, Anna C and Murphy, Andrew J and Baratchi, Sara and Jandeleit-Dahm, Karin A M},
  title = {The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing},
  journal = {Diabetes},
  year = {2024},
  volume = {73},
  number = {9},
  pages = {1495--1512},
  doi = {10.2337/db23-0167}
}
Kostenlos starten →